Kennedy S.H., Fvedisova A., Giménez-Montesinos N., Belaïdi C., Christian De, Bodinat, Mosolov S.N.Kennedy S.H.Kennedy S.H., Fvedisova A., Giménez-Montesinos N., Belaïdi C., Christian De, Bodinat, Mosolov S.N., Fvedisova A.Kennedy S.H., Fvedisova A., Giménez-Montesinos N., Belaïdi C., Christian De, Bodinat, Mosolov S.N., Giménez-Montesinos N. et al. A placebo-controlled study of three agomelatine dose regimens (10 mg, 25 mg, 25-50 mg) in patients with major depressive disorder // European Neuropsychopharmacology. 2014. Vol 24, № 4. P. 553-563.

Ключевые слова: - - - -